CDK2 and prostate carcinoma: found coatomer subunit beta 2 knockdown increased the fraction of human prostate carcinoma cells in the G1 phase and decreased the fraction of cells in the S phase via the p21Waf1/Cip1/p27Kip1 and the cyclin D1/CDK2/CDK4 pathways (31).